Wire Stories

Origin Materials and SCGP Announce Strategic Partnership in Innovation and Sustainability to Explore Licensing Origin Technology for ASEAN-Based Plant

The companies have signed a joint development agreement (JDA), with testing of eucalyptus feedstock underway targeting applications in food packaging,…

4 years ago

Luminar Expands in Asia with New Factory; Standardized on New Variant of the Volvo EX90

New 4-seater Volvo variant, the EX90 Excellence, launches in Shanghai with Luminar as standard Luminar signs deal with TPK for…

4 years ago

Avistone Announces Interim Data Results on PLB1004 in Patients with EGFR mutant NSCLC Patients at AACR 2023

BEIJING--(BUSINESS WIRE)--Avistone Biotechnology (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, today announced interim results…

4 years ago

The Sixth CIIE Holds Global Promo Event Series to Engage More Partners

SHANGHAI--(BUSINESS WIRE)--$CHINA #china--Since its inception in 2018, the area of its business exhibition increased from 270,000 square meters to 366,000…

4 years ago

Introducing Certuity: A Multibillion Dollar Multifamily Office Formerly Known As Camden Capital

NORTH PALM BEACH, Fla.--(BUSINESS WIRE)--Camden Capital, LLC, a multibillion dollar multifamily office and registered investment adviser providing bespoke wealth management,…

4 years ago

$2,000 Jackpot and 200+ Free Spins at Juicy Stakes Casino

Take a look at what’s on offer online this week SYDNEY--(BUSINESS WIRE)--Strapped in and all set for another rollercoaster ride…

4 years ago

NelsonHall Recognized Datamatics as an ‘Innovator’ in the NEAT Vendor Evaluation for Financial Services Cloud, SaaS & BPaaS in the Cloud Services market segment

LIVONIA, Mich. & MUMBAI, India--(BUSINESS WIRE)--#ApplicationTesting--Datamatics, a global Digital Technologies, Operations and Experiences Company, is recognized as an 'Innovator' in…

4 years ago

ECCMID 2023: Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja® / Fetroja® (cefiderocol) Against Some of the Most Difficult-to-Treat Gram-Negative Bacterial Pathogens

A retrospective chart review interim analysis demonstrated that cefiderocol achieved clinical cure in 65% and 60% of patients with Pseudomonas…

4 years ago